Abiopharma

QuickLogic Set to Join Russell 2000® and Russell 3000® Indexes

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

Bristol Myers Squibb - Izalontamab Brengitecan (Iza-Bren) Demonstrates Statistically Significant and Clinically Meaningful Improvements in Overall Survival and Progression-Free Survival in Patients with Triple-Negative Breast Cancer and Esophageal Squamous Cell Carcinoma

RedHill Biopharma - RedHill Biopharma Advancing Opaganib Options for Novel Dual Host Directed and Direct Acting Antiviral Approach for Ebola Outbreak Biodefense Platforms

Aethlon Medical to Release Fiscal Year End Financial Results and Host Conference Call on June 10, 2026

McKesson Corporation - McKesson Closes Strategic Investment with Apollo Funds for Minority Interest in Medical-Surgical Solutions

Enveric Biosciences Initiates Investigational New Drug (IND)-enabling Genotoxicity Studies of Lead Neuroplastogen Candidate EB-003

BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform

Multidisciplinary Physician Panel to Share Real-World Benefits of bioAffinity Technologies’ Noninvasive CyPath Lung Cancer Test in Upcoming Society for Advanced Bronchoscopy Webinar

ProKidney Appoints Kenneth Locke as Chief Technical Officer